Navigation Links
Harwood Feffer LLP Announces Investigation of Advaxis, Inc.
Date:1/23/2015

NEW YORK, Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ADXS), concerning whether the board has breached its fiduciary duties to shareholders.

On January 21, 2015, an article was published on an investing website reporting that Advaxis had misrepresented the clinical data for its ADXS-HPV drug in a recent corporate presentation by exaggerating its effectiveness.  Company stock fell over 25% on this news.

Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.

If you own Advaxis shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com 
Follow us on Twitter: @HarwoodFeffer

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm. 

The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo - http://photos.prnewswire.com/prnh/20120215/MM54604LOGO

 


'/>"/>
SOURCE Harwood Feffer LLP
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of Avanir Pharmaceuticals, Inc.
2. Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc.
3. Harwood Feffer LLP Announces Investigation of Santarus, Inc.
4. Harwood Feffer LLP Announces Investigation of Transcept Pharmaceuticals, Inc.
5. Updated: Harwood Feffer LLP Announces Investigation of Edwards Lifesciences Corporation
6. Harwood Feffer LLP Announces Investigation of OvaScience, Inc.
7. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
8. Harwood Feffer LLP Announces Investigation of MAP Pharmaceuticals, Inc.
9. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
10. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
11. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2019)... ... September 12, 2019 , ... ... , revenue cycle management services, integrated practice management, and patient engagement solutions, ... Sponsor at National User Conference (NUCON) 2019 . The annual conference ...
(Date:9/11/2019)... ... September 12, 2019 , ... ... Best Practices, An FDAnews Webinar, Thursday, Sept. 26, 2019, 1:30-3:00 p.m. EDT, ... (DSCSA) implementation requirements? Is the company clear on nuances of the guidelines regulating ...
(Date:9/11/2019)... ... September 11, 2019 , ... Radiology… gastroenterology… ophthalmology… pathology… , ... evaluate medical images. In fact, image analysis software represents one of the fastest-growing ... to AI-based image analysis, one will be left behind. , As both a ...
Breaking Medicine Technology:
(Date:9/17/2019)... SARASOTA, Fla. (PRWEB) , ... September 17, 2019 ... ... plans and Dental Service Organizations (DSOs) has earned Michael Cole, Vice President of ... presented today by the National Association of Dental Plans (NADP) at their annual ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... join the largest accountable care organization (ACO) in the country, the company announced ... groundbreaking collaboration to improve care quality and increase cost efficiency. This opportunity is ...
(Date:9/17/2019)... ... September 17, 2019 , ... Genomenon ... , with the goal of providing resources to assist researchers and encourage pharmaceutical ... progressive disease causing abnormal iron deposits in the brain. , BPAN Warriors ...
(Date:9/14/2019)... Okla. (PRWEB) , ... September 14, 2019 , ... ... cannabis industry, has time and again tried to bring the most relevant and important ... ray of hope on an increasingly large number of people across the world suffering ...
(Date:9/11/2019)... ... September 11, 2019 , ... Global Education Group (Global), ... (CME) provider, is the official accreditor for PAINWeek, the largest US pain conference ... topics, as it has done for the past ten years. In addition, the ...
Breaking Medicine News(10 mins):